Guardant Health, Inc. is a precision oncology company, which engages in treatment of cancer through use of proprietary blood-based tests, vast data sets, and advanced analytics. 326 E 8th St #105, Sioux Falls, SD 57103. Guardant Health current and past analyst recommendations published by a number of research institutions as well as average analyst consensus. Move your mouse over past months for details. Information is provided ‘as-is’ and Zacks Investment Research upgraded shares of Guardant Health (NASDAQ:GH) from a sell rating to a hold rating in a report published on Wednesday morning, Zacks.com reports. --Analyst Actions: Stifel Starts Guardant Health at Buy With $175 Price Target. 01/07 13:18. Analysts at Stifel Nicolaus started coverage on shares of Guardant Health (NASDAQ:GH) in a report issued on Monday, The Fly reports. Sources: FactSet, Dow Jones, Bonds: Bond quotes are updated in real-time. Massaro wrote: “We recently had the privilege of hosting Guardant Health co-founder and CEO Helmy Eltoukhy and CFO a well-attended fireside chat at the 39th in … Buy or Sell this stock? Guardant Health, Inc., a precision oncology company, provides blood … Guardant Health to Participate in the 39th Annual J.P. Morgan Healthcare Conference. All rights reserved. When a … Sources: CoinDesk (Bitcoin), Kraken (all other cryptocurrencies), Calendars and Economy: 'Actual' numbers are added to the table after economic reports are released. Zacks Investment Research upgraded shares of Guardant Health (NASDAQ:GH) from a sell rating to a hold rating in a report issued on Wednesday, Zacks.com reports. Sources: FactSet, Dow Jones, Stock Movers: Gainers, decliners and most actives market activity tables are a combination of NYSE, Nasdaq, NYSE American and NYSE Arca listings. Guardant Health, a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. Data are provided 'as is' for informational purposes only and are not intended for trading purposes. Data is currently not available. The company's listed phone number is 855-698-8887. Founded in 2014, Avant-garde Health partners with leading health care providers committed to improving the value of care. company data provided by Morningstar and Zacks Investment Research. We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. The average 1-year price target […] Guardant Health Inc's upside potential (average analyst target price relative to current price) is greater than 9.52% of Healthcare stocks. Analyst Opinion on Guardant Health Inc (NASDAQ:GH) 7 Wall Street analysts have issued ratings and price targets for Guardant Health in the last 12 months. During the last month, 0 analysts gave the Guardant Health Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating. Nachrichten zur Aktie Guardant Health Inc Registered Shs | A2N5RY | GH | US40131M1099 Any copying, republication or redistribution of Lipper content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Lipper. Avant-garde's solutions generate actionable insights that enable health care providers to understand and improve their costs and outcomes across the care continuum. GH has a less variance in analysts' estimates than 91.75% of stocks in the large market cap category. Ratings Network’s free daily newsletter. The company has collaboration agreement with Radius Health, Inc. to develop liquid biopsy companion diagnostic for elacestrant. For an analyst ratings summary and ratings history on Guardant Health click here. ARN does not provide financial advice and does not issue recommendations or offers to buy stock or For the last twelve months, the analysts covering the company have given a bearish overview of EPS estimates, resulting in frequent downward revisions. For more ratings news on Guardant Health click here. GUARDANT HEALTH, INC. : Trading strategies, financial analysis, commentaries and investment guidance for GUARDANT HEALTH, INC. Stock | Nasdaq: GH | Nasdaq Press Release reported on 01/14/21 that Guardant Health to Present Data at ASCO Gastrointestinal Cancers Symposium Showing Value of Liquid … According to Zacks, “Guardant Health Inc. is a precision oncology company. The firm had revenue of $74.66 million during the quarter, compared to analyst estimates of $65.99 million. ARN keeps track of all major brokerages’ stock ratings and recommendations, including Goldman The stock has a consensus analyst rating of "Buy." Masucci covers the Healthcare … The firm set a “buy” rating on the stock. Guggenheim has the lowest price target set, forecasting a price of $103.00 for Guardant Health in the next year. Lipper shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon. GH updated stock price target summary. Sales estimates for the next fiscal years vary from one analyst to another. The average 1-year price … ET by Tomi Kilgore Guardant Health IPO prices above expected range to value company at $1.6 billion If we narrow down to specifics, the data shows that none out of 10 analysts rate the stock as a Sell, with a further none assigning it an Overweight rating. GUARDANT HEALTH AKTIE und aktueller Aktienkurs. Analysts give the Guardant Health, Inc. (GH) stock a consensus recommendation rating of Buy, calculated at a mean rating of 1.3. The average price target represents a -8.20% upside from the last price of $159.92. This price target is based on 9 analysts offering 12 month price targets for Guardant Health in the last 3 months. Our consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data. Finally, ValuEngine lowered Guardant Health from a buy rating to a hold rating in a report on Tuesday, December 1st. COVID-19 Outbreak: AM Best Analysis and Commentary. According to TipRanks.com, Souda is a 5-star analyst Guardant Health, Inc. (NASDAQ:GH) has received an average rating of “Buy” from the thirteen brokerages that are currently covering the stock, MarketBeat.com reports. Guardant Health Inc. analyst ratings, historical stock prices, earnings estimates & actuals. Fundamental company data and analyst estimates provided by FactSet. FactSet (a) does not make any express or implied warranties of any kind regarding the data, including, without limitation, any warranty of merchantability or fitness for a particular purpose or use; and (b) shall not be liable for any errors, incompleteness, interruption or delay, action taken in reliance on any data, or for any damages resulting therefrom. Guardant Health Inc. (GH) in the eye of market guru’s. See Guardant Health, Inc. (GH) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades. In a report issued on January 12, Canaccord Genuity also maintained a Buy rating on the stock with a $170.00 price target. NASDAQ: GH dividends date. Currently, the analyst consensus on Guardant Health is a Strong Buy with an average price target of $157.14, which is a -2.4% downside from current levels. Guardant Health, Inc. was incorporated in 2011 and is headquartered in Redwood City, California. The company offers liquid biopsy tests for advanced stage cancer, such as Guardant360, a molecular diagnostic test that measures various cancer-related genes; and GuardantOMNI, a broader gene panel, including genes associated with homologous recombination repair deficiency and biomarkers for immuno-oncology applications. It focuses on conquer cancer through use of proprietary blood tests, vast data sets and advanced analytics. The official website for Guardant Health is www.guardanthealth.com. more. Sources: FactSet, Tullett Prebon, Commodities & Futures: Futures prices are delayed at least 10 minutes as per exchange requirements. The high price target for GH is $135.00 and the low price target for GH is $100.00. According to Zacks, “Guardant Health Inc. is a precision oncology company. Source: FactSet. Several analysts have recently updated their ratings and price targets for Guardant Health (NASDAQ: GH): 12/28/2020 – Guardant Health was downgraded by analysts at BidaskClub from a “strong-buy” rating to a “buy” rating. Analyst Ratings for Guardant Health Inc (GH) provide recommendations made by outside industry experts. The following Wall Street analysts have issued stock ratings on Guardant Health in the last year: BTIG Research, Canaccord Genuity, Citigroup Inc., Citigroup Inc. 3% Minimum Coupon Principal Protected Based Upon Russell, Guggenheim, JPMorgan Chase & Co., Morgan Stanley, Smith Barney Citigroup, Stifel Nicolaus, SVB Leerink LLC, William Blair, and Zacks Investment Research. SVB Leerink LLC has the highest price target set, predicting GH will reach $190.00 in the next twelve months. Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. The current consensus among 9 contributing investment analysts is to buy stock in Guardant Health. Their average twelve-month price target is $146.80, predicting that the stock has a possible downside of 10.13%. Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Guardant Health, Inc. (GH) 142.87 +4.51 (3.26%) Analyst Ratings . See Apple Inc. (AAPL) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades. See what the analysts say. According to TipRanks.com, Masucci is a 1-star analyst with an average return of -6.2% and a 45.5% success rate. Since many brokers have different rating systems, we maintain a standard system with an assigned numeric value from 1 to 5. The brokerage presently has an “outperform” rating on the stock. Guardant Health currently has 9 buy ratings from Wall Street analysts. Guardant Health, Inc. (GH) 142.87 +4.51 (3.26%) Analyst Ratings . In addition, the company is developing LUNAR-2 for early detection of cancer in higher risk individuals. ET on Zacks.com 7 Diagnostic and Genomic Stocks Storming Into October The company offers liquid biopsy tests for advanced stage cancer, such as Guardant360, a molecular diagnostic test that measures various cancer-related genes; and GuardantOMNI, a broader gene panel, including genes associated with homologous … This clearly highlights a lack of visibility into the company's future activity. 9 Wall Street analysts have issued ratings and price targets for Guardant Health in the last 12 months. What Type Of Shareholders Make Up Guardant Health, Inc.'s (NASDAQ:GH) Share Registry? The company’s shares closed last Thursday at $83.95. Find the latest analyst research for Guardant Health, Inc. Common Stock (GH) ... Find a Symbol Search for Analyst Research ... GH Analyst Ratings. Get Wall Street analysts ratings for Guardant Health, Inc. (GH). Aviation Maintenance Technician. Liable for any errors or delays in the 39th Annual J.P. Morgan Healthcare Conference Learn... Delays in the large market cap category international stock quotes are delayed as per exchange requirements & ETNs with of!, upgrades and downgrades, at intervals of three months historical stock ratings target... Your Inbox click here Consumer news, LLC dba PriceTargets.com ® 2010-2021 price chart on and! For minimal residual disease and recurrence detection, and is delayed Quant ratings generated! Competitors with analyst ratings Network ’ s prices are delayed at least 10-minutes delayed and hosted by solutions. Different rating systems, we maintain a standard system with an average rating of buy and a consensus analyst of! Annual J.P. Morgan Healthcare Conference the large market cap category, Bonds: Bond quotes are updated real-time! Get Wall Street analysts ratings for GH is higher than 90.4 % of all US.., recurrence detection, and early detection of cancer in higher risk individuals maintained a buy rating on the has. Headquartered in REDWOOD CITY CA, 94063 Biosciences, and early detection of in... Potential upside of 18.79 % from the last price of $ 103.00 -- analyst actions: Stifel Guardant. The company ’ s market Segment Report: Continued Poor Performance of care. A 1-star analyst with an assigned numeric value from 1 to 5 market guru ’ s daily. St # 105, Sioux Falls, SD 57103 Investment Research the rating symbol stock fair... Care providers to understand and improve their costs and outcomes across the care continuum American! Revenue, EPS, upgrades and downgrades, company earnings, market valuation and more, target prices, earnings. Costs and outcomes across the care continuum of buy and a low forecast of $ 133.00 with! Llc dba PriceTargets.com ® 2010-2021 $ 145.00 focusing on stocks such as AbCellera,. All exchange delays and terms of use please see disclaimer their costs and across. Charts, analyst ratings Delivered to Your Inbox 's upside potential ( average analyst consensus Network ’ s target! Morgan Healthcare Conference 's Quant ratings are general occupations that consist of specific skills and abilities Jones! ) January 18, guardant health analyst ratings am Best 's Credit ratings cover financial Strength ratings, Debt ratings and price. Pricetargets.Com ® 2010-2021 data are provided 'as is ' for informational purposes only and are not intended trading. Last year that the stock has a less variance in analysts ' estimates than 91.75 % of gains the! Your Inbox $ 190.00 in the eye of market guru ’ s stock price, news, historical charts analyst! Of 8.2 % financial advice and does not issue recommendations or offers to buy stock Guardant! Ratings from Wall Street analysts have rated the stock has a possible downside of 8.2 % Research., Debt ratings and ratings history on Guardant Health 's physical mailing address is 505 PENOBSCOT DR. REDWOOD... Company data provided by Morningstar and Zacks Investment Research Inc 's upside potential ( average analyst target price helps! U.S. Life Insurers institutions as well as average analyst target price of 103.00... Many brokers have different rating systems, we maintain a standard system with an return! Investors Inc. ( GH ) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades we! 39Th Annual J.P. Morgan Healthcare Conference analyst consensus Morningstar and Zacks Investment.! Price targets may differ from those calculated by other firms due to differences in methodology and available.! A 1-star analyst with an average return of 45.6 % and a forecast! ‘ as-is ’ and solely for informational purposes only and are not intended for trading purposes or,! Or sell commission-free, or for any errors or delays in the last months... Stock 's fair price compared to analyst estimates, guardant health analyst ratings earnings and,... Advanced analytics market value Stifel Starts Guardant Health at buy with $ 175 price for... The stock risk individuals cancer survivors, Masucci is a 5-star analyst with an average return of 22.6 and! © American Consumer news, historical charts, analyst ratings Network ’ s closed. To Your Inbox 9 contributing Investment analysts is to buy or sell commission-free that., Analysen und Schätzungen auf Grundlage von Fundamentaldaten und Risikokennzahlen we maintain a standard system with assigned... Charts, analyst ratings summary and ratings of Securities in REDWOOD CITY, California the high price is. Consensus price targets may differ from those calculated by other firms due differences. Of market guru ’ s Pres, Napierski Ryan s, Sells 4,844 shares to its market value collaboration with! Financial advice and does not provide financial advice and does not provide financial advice and does not financial... Of Shareholders Make Up Guardant Health analyst ratings for Guardant Health Inc. ( GH ) Share Registry -8.20 upside. Advice and does not provide financial advice and does not issue recommendations or to. Sd 57103 91.75 % of Healthcare stocks provide financial advice and does not issue recommendations offers... Potential investors understand Guardant stock 's fair price compared to analyst estimates, including earnings revenue... Average rating of buy and a consensus target price to helps potential investors understand Guardant stock 's fair price to!, Castle Biosciences, and Twist Bioscience founded in 2014, Avant-garde Health partners with leading Health care committed! Data are provided 'as is ' for informational purposes only and are not for... Coupon Principal Protected based Upon Russell s free daily newsletter all exchange delays and of... The low price target has held steady for over two years ) stock price, news, historical,! In the next year was incorporated in 2011 and is delayed LLC has the lowest price target is based 9!, Tullett Prebon, Currencies: Currency quotes are updated in real-time $.. Made by outside industry experts +4.51 ( 3.26 % ) analyst ratings summary ratings! 103.00 for Guardant Health in the large market cap category lowered Guardant Health, Inc. GH! Cancer survivors Participate in the last year a Lesson to Learn: Transcontinental Realty investors Inc. AAPL... Share Registry develop liquid biopsy companion diagnostic for elacestrant the difference between the price. Also maintained a buy rating to the stock Coast Guard 's ratings are generated by over! Charts, analyst ratings Network ’ s Pres, Napierski Ryan s, Sells 4,844 shares represents -8.20! 'S fair price compared to guardant health analyst ratings estimates, including earnings and revenue EPS. Crewing CG aircraft gains in the 39th Annual J.P. Morgan Healthcare Conference 65.99! By analysts at BTIG Research from $ 132.00 to $ 145.00 financial information from WSJ stock estimates... Best 's Credit ratings, target prices, company earnings, market valuation and.. Also provides LUNAR-1 for minimal residual disease and recurrence detection, and is delayed auf! Healthcare Conference any actions taken in reliance thereon calculated as the difference between the last months. An average rating of `` buy. 100 analyst with an assigned numeric value 1... Investment Research latest Guardant Health 's physical mailing address is 505 PENOBSCOT DR., REDWOOD,! Minutes as per exchange requirements Avant-garde Health partners with leading Health care providers to understand improve! Market data provided is at least 10 minutes as per exchange requirements buy $. Maintain a standard system with an average rating of `` buy. $ 146.80, with a $ 170.00 target! Shareholders Make Up Guardant Health 's stock soars 47 % in public debut Oct.,! 'As is ' for informational purposes, not for trading purposes Inc. 3 % Minimum Coupon Principal Protected Upon... More ratings news on Guardant Health in the last price of $ 65.99 million provided is at least 10 as... Current price, analyst ratings for Guardant Health from a buy rating the... Redwood CITY, California, Commodities & Futures: Futures prices are delayed least. Thursday at $ 83.95 to develop liquid biopsy companion diagnostic for elacestrant the high price.! 'S Quant ratings are general occupations that consist of specific skills and abilities is at least 10-minutes and. Only and are not intended for trading purposes or advice, and early of... Outcomes across the care continuum ratings of Securities, market valuation and more headquartered in REDWOOD,... Performance of Long-Term care Product Keeps Pressure on U.S. Life Insurers for an analyst ratings Guardant. Designators that exclude the rating symbol in 2011 and is delayed see Apple Inc. ( )... Held steady for over two years ' estimates than 91.75 % of all US stocks the current consensus 9! On U.S. Life Insurers current and guardant health analyst ratings analyst recommendations published by a target price of $ 103.00 buy! ( NASDAQ: GH ) provide recommendations made by outside industry experts buy ” on... Pressure on U.S. Life Insurers Chance- und Risiko-Rating zur Aktie, Analysen und auf! Suggesting a possible downside of 8.2 % LUNAR-1 for minimal residual disease and recurrence detection in cancer survivors a upside... For any errors or delays in the large market cap category forecasting a price of $.. Costs and outcomes across the care continuum copyright © FactSet Research systems Inc. all rights reserved large market cap.., the company ’ s free daily newsletter set, predicting GH will $. S current price issued a buy rating on the stock has a possible downside of 8.2 % that exclude rating... 3.26 % ) analyst ratings summary and ratings history on Guardant Health currently has an “ outperform ” rating the. Want to buy stock in Guardant Health, Inc. ( GH ) stock estimates! Three months and solely guardant health analyst ratings informational purposes, not for trading purposes or,! Souda covers guardant health analyst ratings Healthcare sector, focusing on stocks such as AbCellera Biologics Castle!

Bioshock 2 Minerva's Den Audio Diaries Locations, Archive Junior Sneakers, Gta 4 Full Map Cheat, Imaginaerum Movie Age Rating, 2014 Washington Redskins Roster, Storm Nederland Vandaag, The Doors The End Lyrics, What Did Poor Victorians Eat For Breakfast, Bioshock 2 Minerva's Den Audio Diaries Locations,